American Society of Clinical Oncology

SHERPA: White

People

  1. Pfister
    Pfister
  2. Stambuk
    Stambuk
  3. Sherman
    Sherman
  4. Lee
    Lee
  5. Shen
    Shen
  6. Baum
    Baum
  7. Dave
    Dave
  8. De Angelis
    De Angelis
  9. Gavrilovic
    Gavrilovic
  10. Ghossein
    Ghossein

Groups

  1. Neuroradiology Service (5)
  2. Radiology, Department of (5)
  3. Department of Medicine (4)
  4. Head and Neck Service (4)
  5. Solid Tumor Oncology Division (4)
  6. Biostatistics Service (3)
  7. Epidemiology and Biostatistics (3)
  8. Population Sciences Research Program (3)
  9. Radiation Oncology, Department of (2)
  10. Surgery (2)
Search Within
  1. "2009"
  2. "Neuroradiology Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Neuroradiology Service (5)
  2. Radiology, Department of (5)
  3. Department of Medicine (4)
  4. Head and Neck Service (4)
  5. Solid Tumor Oncology Division (4)
  6. Biostatistics Service (3)

More Groups

People
  1. David Pfister (4)
  2. Hilda Stambuk (4)
  3. Matthew Fury (4)
  4. Donna Lisa (3)
  5. Eric Sherman (3)
  6. Diane Carlson (2)

More People

Years
  1. 2009 (5)
Publications
  1. Journal of Clinical Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of depsipeptide (DEP) in radioiodine (RAI)-refractory metastatic nonmedullary thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Fury, M. G.; Tuttle, R. M.; Ghossein, R.; Stambuk, H.; Baum, M.; Lisa, D.; Su, Y. B.; Shaha, A.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
    Meeting Abstract

    Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases
    Meeting Abstract

    Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E; RAD001) + low-dose weekly cisplatin (C) for patients with advanced solid tumors: Preliminary results
    Meeting Abstract

    Fury, M. G.; Sherman, E.; Stambuk, H.; Haque, S.; Lisa, D.; Shen, R.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save